News and insights

Discover the latest news, insight and developments from Frontier IP and its portfolio companies here.

14/3/2024

Half year results: maturing portfolio makes good commercial and technical progress

Pre-tax profits reach £1.4 million and the fair value of the equity portfolio rises 6 per cent to £35 million despite difficult market and economic conditions.

Read more

25/1/2024

Alusid outlines plans for 2024 after raising £1.1 million

Alusid is developing premium-quality tiles with even higher levels of recycled material, as well as floor tiles, says CEO Alasdair Bremner in this Proactive video. The company is also exploring international expansion and IPO options.

Read more

22/1/2024

Octopus backs Alusid as part of £1.1 million fundraising

Alusid now exploring IPO options and expansion into new product ranges and territories following £500,000 investment from Octopus AIM VCT plc and Octopus AIM VCT 2 plc funds.

Read more

18/1/2024

Horns of plenty: unicorns, narwhals and the changing company valuation landscape

Once rare financial unicorns have become all too common in the past decade, but are now facing geopolitical and economic headwinds. In this presentation to premier global executive knowledge network FS Club, Chief Executive Neil Crabb explains what narwhals can teach us that unicorns can’t.

Read more

13/12/2023

The Vaccine Group appoints industry experts to new Advisory Board

The Vaccine Group has appointed three animal health industry experts to a new Advisory Board to support scale up of the Company’s novel vaccine platform technology.

Read more

31/10/2023

Full year results 2023: good technical and commercial progress in challenging markets

Alusid, Nandi Proteins, Cambridge Raman Imaging, Celerum, and Fieldwork Robotics are all either generating revenues or are about to start, taking further strides forward to commercial viability. The day moves closer for a second portfolio company to follow Exscientia in launching an initial public offering or to execute a trade sale.

Read more

31/10/2023

Dame Julia King, Baroness Brown of Cambridge, to become Frontier IP Chair

Current Chair Andrew Richmond will step down from the Board of Directors at the next annual general meeting, expected to be held in December 2023.

Read more

26/10/2023

Bio-materials developer DeakinBio joins our portfolio

DeakinBio is developing advanced bio-based materials from organic waste and widely available inorganic powders. Frontier IP has taken a 32.8 per cent equity stake

Read more

25/9/2023

Exscientia’s new AI drug discovery collaboration with Merck worth up to $674 million

The collaboration will focus on the discovery of novel small molecule drug candidates across oncology, neuroinflammation and immunology.

Read more

12/9/2023

Mark Gerhard, technology pioneer and serial entrepreneur, joins Pulsiv as Chairman

The former CEO of computer games developer Jagex has a long history of growing and exiting businesses in the games, artificial intelligence and cyber-security sectors.

Read more

15/8/2023

Fieldwork Robotics raises £1.5 million and appoints new CEO

Fieldwork Robotics is aiming to have 100 raspberry-harvesting robots in operation by 2025 following a £1.5 million investment from Elbow Beach Capital, a specialist in sustainable energy, decarbonsisation and social impact businesses.

Read more

26/7/2023

Emporia4KT reaches concludes successfully

A major pan-European project to boost technology transfer in the Blue Economy across the Atlantic seaboard has come to end. Learn more about how Frontier IP helped.

Read more

9/5/2023

Topps Tiles launches Alusid-made wall tiles

Topps Tiles, the UK’s no.1 tile specialist, has launched Principle, a range of mass-produced wall tiles made from recycled materials made by portfolio company Alusid.

Read more

15/3/2023

Nigel Grierson and Dr David Holbrook join the Frontier IP board of directors

Dame Julia King, Baroness Brown of Cambridge becomes Senior Independent Director as Frontier IP broadens experience on board with two new non-executive directors.

Read more